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Although the basic functional and pharmacological properties of mitochondrial Ca 2ϩ uptake mechanisms have been discovered over 50 yr ago, the molecular identities responsible for these mechanisms have remained a mystery until very recently. Mitochondrial Ca 2ϩ influx was principally considered to result from a single transport mechanism mediated by the mitochondrial Ca 2ϩ uniporter (MCU) initially due to near complete inhibition by ruthenium red and lanthanides. Finally, through RNA interference studies, several groups (4, 17, 52, 67) discovered the molecular identity of MCU and its regulatory proteins in nonexcitable cells. Although in these studies MCU was confirmed as the most dominant Ca 2ϩ influx mechanism (see also Ref. 42) , interestingly, mitochondrial morphology, respiration, and cell viability remain normal in MCU knockout or MCU-overexpressing cells (4, 17, 52, 67) even though Ca 2ϩ influx is critical in the regulation of these main mitochondrial functions. In addition, recent reports using mathematical analysis (81) and electrophysiological experiments (21) have suggested that cardiac mitochondria Ca 2ϩ influx through MCU might be slow and small under the physiological range of cytosolic Ca 2ϩ concentrations ([Ca 2ϩ ] c ; i.e., 0.1-20 M) compared with other cytosolic Ca 2ϩ fluxes such as sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA). Therefore, these results have raised another hypothesis: that additional Ca 2ϩ uptake pathways must exist in the regulation of these critical mitochondrial functions. Indeed, subsequent studies have identified additional Ca 2ϩ uptake pathways, such as leucine zipper-EF hand-containing transmembrane protein 1 (Letm1) (36) , rapid mode of uptake (RaM) (75) , and coenzyme Q 10 (10), which exhibit different Ca 2ϩ affinity, uptake kinetics, and pharmacological characteristics from the original MCU theory (for a review, see Ref. 64) . Moreover, it has been recently shown that cardiac mitochondria contain two modes of binuclear ruthenium complex-sensitive Ca 2ϩ uptake, a high Ca 2ϩ affinity rapid uptake mode and a low Ca 2ϩ affinity slow uptake mode, that are responsible for modulating oxidative phosphorylation and Ca 2ϩ buffering, respectively (80) . However, the detailed molecular compositions of the ion channels/ transporters responsible for the Ca 2ϩ uptake mechanism, especially in excitable cells, including cardiomyocytes, remain elusive.
Among these studies, a skeletal muscle-type ryanodine receptor (RyR), RyR type 1 (RyR1), was also found as one of the mitochondrial Ca 2ϩ influx mechanisms in cardiomyocytes with a known molecular identity reported from our group, termed "mitochondrial RyR1" (mRyR1) (for reviews, see Refs. 64, 71, and 72). We first found that a low level of RyR1 is expressed at the mitochondrial inner membrane in cardiomyocytes, as shown by a combination of biochemical and cell biological experiments, and finally confirmed its role in cardiomyocytes as a fast Ca 2ϩ uptake pathway by electrophysiological experiments (1, 7, 8, 72) . Since mRyR1 shows a bellshaped Ca 2ϩ -dependent activation (bimodal activation) in a physiological range of [Ca 2ϩ ] c , this unique property places mRyR1 as an ideal candidate for sequestering Ca 2ϩ quickly and transiently under physiological [Ca 2ϩ ] c oscillation, such as during heart beats. The molecular identity of RyR1 in cardiac mitochondria was carefully analyzed and confirmed using not only native cardiomyocytes but also those obtained from RyR1 knockout mouse hearts (8) . Interestingly, in RyR1 knockout mouse heart mitochondria, the respiratory control index is very low (Х1) and [Ca 2ϩ ] c does not stimulates O 2 consumption, suggesting that mRyR1 is required for both the basal metabolic state and Ca 2ϩ -dependent acceleration of the TCA cycle in cardiomyocytes (8) even though its expression level is much lower than RyR2, which is the main RyR isoform expressed in the cardiac sarcoplasmic reticulum (SR)/endoplasmic reticulum (ER) (44) .
In addition, recent reports have indicated that changes in mitochondrial dynamics/morphology are closely related to mitochondrial function, including ATP production and cellular function, suggesting that mitochondrial form and function are tightly linked (for a review, see Ref. 25) . We (26) have also reported that mitochondrial Ca 2ϩ influx is a key regulator for mitochondrial morphology in cardiac cells. Therefore, we hypothesize that Ca 2ϩ sequestration via mRyR1 into cardiac mitochondria regulates mitochondrial morphology, concomitantly efficiently stimulating oxidative phosphorylation for ATP production during excitation-contraction coupling to meet metabolic demands. To deal with the potential issue of low expression of RyR1 in native cardiomyocytes (8), we overexpressed RyR1 in cardiac H9c2 myoblasts and tested whether RyR1 overexpression can increase both basal metabolism and Ca 2ϩ -dependent ATP production. We also observed the effect of RyR1 overexpression on mitochondrial morphology. Here, we showed that 1) overexpression of RyR1 (but not RyR2 or MCU) leads to mitochondrial fragmentation and 2) cells that overexpress RyR1 had a higher mitochondrial ATP concentration ([ATP] mt ) under basal conditions and accelerated [Ca 2ϩ ] cdependent ATP production. We also found that fragmented mitochondria possess bigger and sustained mitochondrial Ca 2ϩ transients compared with basal tubular mitochondria in H9c2 cells, suggesting the existence of a critical link between the mitochondrial form (morphology) and function (Ca 2ϩ -dependent ATP production). These results indicate that mRyR1 and MCU have distinct roles in the regulation of mitochondrial form and function in cardiac H9c2 myoblasts. biosensor (Mitycam) in pcDNA3.1(ϩ) (40) and mitochondria-targeted ATP biosensor Ateam (mt-Ateam) in pcDNA3 (kindly provided by Dr. Hiromi Imamura, Kyoto University, Kyoto, Japan) (29); SR-targeted GFP (GFP-KDEL or SR-GFP) in pcDNA3.1/Zeo(ϩ) (an ER targeting sequence that corresponds to the NH 2-terminal 17 amino acids of mouse calreticulin was fused to the NH2-terminus of EGFP and an ER retention signal peptide, KDEL, was inserted into its COOH terminus; kindly provided by Drs. Katsuhiko Mikoshiba and Hiroko Bannai, RIKEN, Wako, Japan) (2); small interfering (si)RNA-GFP in pLKO.1 puro (63) (Addgene, Cambridge MA); GFP-tagged Letm1 in pEGFP-N1 (68); pcDNA3.1(ϩ) (Invitrogen, Grand Island, NY); and pEGFP-C1 (Clontech, Mountain View, CA). Full-length Mitycam was dissected from pcDNA3.1(ϩ) and was inserted into pCI-neo (Clontech) at EcoR1 and Not1 sites. Full-length RyR1-mfGFP was dissected from pcDNA5/FRT/TO and was inserted into pcDNA3.1(ϩ) at HindIII and EcoRV sites.
MATERIALS AND METHODS

Plasmids
The following antibodies were used in the experiments: antiRyR1 antibody (ARR-001) from Alomone Labs ( All reagents were purchased from Sigma-Aldrich unless otherwise indicated. Coenzyme Q 10 (TCI America, Portland, OR) was dissolved in ethanol. Fulo-3-AM, fura red-AM, MitoSox red, and tetramethyl rhodamine ester (TMRE) (Invitrogen) were dissolved in DMSO.
Cell culture, transfection, and infection. A rat cardiac myoblast cell line (H9c2 cells; American Type Culture Collection, Manassas, VA) was maintained in high-glucose (4.5 g/l) DMEM (Mediatech/Corning, Corning NY) supplemented with 10% FBS (GIBCO, Grand Island, NY), 100 U/ml penicillin, 100 g/ml streptomycin (Mediatech/Corning), and 1% L-glutamax (Invitrogen) at 37°C with 5% CO2 in a humidified incubator (84) . This cell line possesses cardiac characteristics in the undifferentiated myoblast condition, expressing both cardiac muscle and skeletal muscle-featured proteins. After differentiation, cells form skeletal-type myotubes and lose their cardiac characteristics (39, 65, 66) . Therefore, experiments were performed under the myoblast condition. A mouse skeletal myoblast cell line (C2C12 cells; kindly provided by Dr. Robert T. Dirksen) and an immortalized RyR1-dyspedic mouse myoblast cell line (1B5 cells; kindly provided by Dr. Paul D. Allen) were maintained in low-glucose (1.0 g/l) DMEM (Sigma-Aldrich), 20% FBS (GIBCO), 100 U/ml penicillin, 100 g/ml streptomycin, 0.25 g/ml fungizone (Lonza, Allendale, NJ), and 2% L-glutamax (Invitrogen) in gelatin-covered dishes at 37°C with 5% CO 2 in a humidified incubator (54) . Cells were transfected with plasmids using FUGENE HD transfection regents (Promega, Madison, WI) as subconfluent cultures (80 -90% cell confluence), replated 24 h after transfection using Acutase (Innovative Cell Technologies, San Diego, CA) for single cell analysis, and used for experiments 48 h after transfection. An equimolar ratio of GFP-tagged proteins and mt-RFP was transfected.
Generation of the RyR1 stably expressing H9c2 cell line. Stable cells carrying RyR1-mfGFP were generated by transfection with mfGFP-RyR1 in pcDNA3.1(ϩ) and selected with 1,600 g/ml G-418 (Mediatech/Corning). One month after selection was started under 1,200 g/ml G-418, cell colonies carrying EGFP expression were isolated under fluorescence microscope and were maintained in 800 g/ml G-418. The expression level of RyR1 was also confirmed by Western blot analysis.
Mitochondrial protein isolation and Western blot analysis. The expression level of RyR1 in mitochondria was determined by isolating mitochondria-enriched protein fractions as previously described (26) . Briefly, H9c2 cells were cultured in 10-cm dishes, washed with isolation buffer (320 mM sucrose, 1 mM EDTA, and 10 mM Tris·HCl; pH7.4), removed from dishes, and collected by centrifuge at 700 g. Cells were resuspended with isolation buffer containing protease inhibitor cocktail (Sigma-Aldrich) and phosphatase inhibitor cocktail (Roche, Mannheim, Germany), homogenized with a Dounce homogenizer, and centrifuged again at 700 g. The supernatant was then collected, and mitochondrial proteins and cytosolic proteins containing SR proteins were separated by centrifugation at 17,000 g. The pellet (mitochondrial protein fraction) was resuspended in lysis buffer (Cell Signaling Technology) containing 20 mM Tris·HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.2% SDS, 2.5 mM sodium pyrophosphate, 1 M ␤-glycerophosphate, 1 mM NaVO4, 50 mM NaF, 1 mM PMSF, and 1% protease inhibitor cocktail (Sigma-Aldrich).
Whole cell lysates were also prepared from H9c2 cells (35) . Cells were washed with cold PBS and then incubated in lysis buffer on ice for 30 min. Cell lysates were centrifuged at 20,000 g for 15 min at 4°C, and supernatants were collected.
The cytosolic fraction containing the SR was isolated from the whole heart or skeletal muscle of adult male c57BL/6 mice using procedures we have previously reported (7, 8) . The protein concentration was determined using the BCA method (Thermo Scientific, Rockford, IL). Cell lysates were separated by SDS-PAGE and transferred to nitrocellulose membranes (Santa Curz Biotechnology, Santa Cruz, CA) and incubated with primary antibodies followed by an incubation with fluorescence-conjugated secondary antibodies (LI-COR Biotechnology, Lincoln, NE). Immunoreactive bands were visualized using the Odyssey Infrared Imaging System (LI-COR Biotechnology).
All animal experiments were performed in accordance with the guidelines on animal experimentation of Thomas Jefferson University. (29) were observed in live H9c2 cells using laser scanning confocal microscopes (FV-500 or FV-1000) with images obtained using Fluoview software (Olympus, Tokyo, Japan) at room temperature. Briefly, cells were plated on glass bottom 35-mm dishes (Matek, Ashland, MA) for observation. The cell culture medium was replaced with Tyrode solution (136.9 mM NaCl, 5.4 mM KCl, 1 mM CaCl 2, 0.5 mM MgCl2, 0.33 mM NaH2PO4, 5 mM HEPES, and 5 mM glucose; pH 7.40, adjusted with NaOH) during observation.
Quantitative colocalization coefficiency analysis. The mitochondrial localization of GFP-tagged proteins was observed by the coexpression of the mitochondrial marker mt-RFP (83) . The expression of mt-RFP itself did not exhibit any significant changes in mitochondrial morphology compared with classical mt-tracker red staining (data not shown). Two-dimensional catterplots of pixel intensities in red (mt-RFP) and green (GFP-tagged proteins) channels were generated with ImageJ software (NIH; see Fig. 2C ). Region 1 and 2 pixels represent signals in channels 1 or 2 only, respectively, and region 3 represents colocalized pixels (see Fig. 2C ). Quantitative colocalization analysis was performed using ImageJ software (NIH) with an Intensity Correlation Analysis plug-in (The Bob and Joan Wright Cell Imaging Facility, Toronto Western Hospital). Colocalization was estimated using Pearson's correlation coefficient and overlap coefficient according to Manders (86) . The values for Pearson's correlation are ranged from 1 to Ϫ1. A value of 1 represents perfect correlation, Ϫ1 represents perfect exclusion, and 0 represents random localization. Cells overexpressing both mt-GFP and mt-RFP were used as positive controls for perfect correlation and colocalization, and cells overexpressing both SR-GFP and mt-RFP were used as negative controls for perfect exclusion (see Fig. 2 ).
Quantitative analyses of mitochondrial morphology. Quantitative analyses of mitochondrial morphology were performed using methods we have previously described (26, 27, 84) . Digital images obtained by confocal microscopy were processed through a convolve filter of ImageJ software (NIH) to obtain isolated and equalized fluorescent pixels. After a conversion to masks, individual mitochondria (particles) were subjected to particle analyses to acquire values for the form factor (FF; the reciprocal of circularity value) and aspect ratio (AR; major axis/minor axis). Both parameters have a minimal value of 1 when it is a perfect circle. High values for FF represent elongated tubular mitochondria, and increased AR values indicate an increase of mitochondrial complexity (length and branching; see also (30, 31, 38) . Cells were incubated with fluo-3-AM (5 M) and fura red-AM (10 M, Invitrogen) in culture medium for 10 min at 37°C. Cells were washed with Tyrode solution and observed using the FV-1000 confocal system (Olympus). The dyes were excited by a 488-nm laser line, and fluorescence was detected in two channels collected through 505-to 605-nm (for fluo-3) and 655-to 755-nm (for fura red) filters. For line scans, a single pixel-wide line across the cytosolic region of a single cell was repetitively scanned at 250 lines/s. All experiments were performed at room temperature. Electron microscopy. Mitochondrial morphology at the ultrastructural level was observed in transmission electron microscopy (EM), as we have previously reported (55) . Specimens were fixed in 2% glutaraldehyde in 0.1 M phosphate buffer, postfixed in 1% osmium tetroxide in the same buffer, dehydrated in ethanol, and embedded in epoxy resin. Thin sections were stained with uranyl acetate and lead citrate. All specimens were observed with a transmission EM (FEI Tecnai 12 TEM equipped with an XR111 11 megapixel chargecoupled device, Advanced Microscopy Techniques, Woburn, MA) at the EM Facility (Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University).
Data and statistical analysis. All results are shown as means Ϯ SE. An unpaired Student's t-test was performed for two data sets. For multiple comparisons, one-way ANOVA followed by a post hoc Tukey test was performed. Statistical significance was set at P Ͻ 0.05.
Simple linear regression analysis (37) and Gaussian fitting in histograms were performed using Origin software (version 6.1, Northampton, MA).
RESULTS
Subcellular localizations of overexpressed RyR1 in cardiac
H9c2 cells. It has been previously reported that cardiac H9c2 myoblasts derived from the embryonic rat heart do not possess detectable expression of RyR1 (19) . Using a specific antibody against RyR1, we confirmed that H9c2 cells did not possess detectable protein levels of RyR1 (Fig. 1A) . The isoform specificity of this antibody was confirmed using cytosolic/SR fractions obtained from mouse skeletal and cardiac muscles (Fig. 1B) . To test the possibility of RyR1 trafficking/retention to cardiac mitochondria, we overexpressed RyR1 in H9c2 cells by DNA plasmid transfection. To deal with the potential issue of low transfection efficiency by conventional transient plasmid transfection methods since the protein molecular weight of RyR1 is relatively large, we also established RyR1 stably overexpressing H9c2 cell lines (see MATERIALS AND METHODS), and the expression level was confirmed by Western blot analysis using the specific antibody against RyR1 (Fig. 1A) . Because RyRs are mainly expressed in the SR or ER, where they mediate Ca 2ϩ release (53) , the purity of our mitochondriaenriched protein fractionation was evaluated by detection of VDAC and SERCA2 by Western blot analysis as mitochondrial and ER/SR markers, respectively (8) . The mitochondriaenriched protein fractionation obtained from the RyR1-overexpressing cell line showed that RyR1 is dominantly found in the cytosolic/SR fraction but is also partially expressed in mitochondria-enriched protein fractionation (Fig. 1C) . We next observed the subcellular localization of overexpressed GFPtagged RyR1 by confocal microscopy using transient RyR1-overexpressing cells (Fig. 2A) . mt-RFP was cotransfected with GFP-tagged RyR1 to detect the mitochondrial localization of RyR1 (83) . GFP-tagged MCU, its regulatory protein MICU1, RyR2, and Letm1 were also overexpressed for comparison. MCU, MICU1, and Letm1 were localized predominantly in mitochondria, similar to the expression pattern of mt-GFP (Fig.  2, A and B) . The subcellular localization of RyR1 and RyR2 showed "mesh-like" patterns indicative of mainly ER/SR localization (59), similar to the SR-GFP expression pattern (Fig.  1A) . However, RyR1 but not RyR2 and SR-GFP was partially colocalized with mt-RFP, which corresponded with our data obtained from mitochondria-enriched protein fraction ( Fig.  2A) . Two-dimensional scatterplots of pixel intensities in red (mt-RFP) and green (GFP-RyR1) channels indicated that a small population of colocalized pixels (yellow) exists in RyR1-overexpressing cells (Fig. 2C) . We next quantitatively assessed the mitochondrial localization efficiency of each GFP-tagged protein by calculating the values of Pearson's correlation (Fig.  2D) . GFP-tagged MCU, MICU1, and Letm1 showed values close to 1, representing that these proteins were highly mitochondria-targeted proteins, as previously reported (4, 17, 67) . The Pearson's value for RyR1 was smaller than those of MCU, MICU1, and Letm1 but was significantly higher than RyR2 and SR-GFP, suggesting that RyR1 has a higher probability of mitochondrial localization compared with RyR2.
RyR1 overexpression induces mitochondrial fragmentation. The above results show that RyR1 has a high possibility of mitochondrial retention compared with RyR2, which is consistent with our previous report (8) using native mitochondria obtained from adult rat cardiomyocytes. Next, to evaluate the mitochondrial morphological changes after RyR overexpression, we analyzed the mitochondrial shapes (mt-RFP signal) obtained from cells expressing GFP-tagged proteins. We only used cells successfully transfected with both mt-RFP and GFP-tagged RyR1 for this analysis. In GFP-RyR1-overexpressing cells, RyR1-overexpressing mitochondria showed a remarkably circular and fragmented morphology (see Fig. 2A,  inset) , whereas there were no obvious changes in mitochondrial morphology in RyR2-( Figs. 2A and 3A) , MCU-, MICU1-, and Letm1-overexpressing cells (Fig. 2C) (84) . We quantitatively evaluated mitochondrial morphology after RyR, MCU, MICU1, and Letm1 overexpression by the values of FF (the reciprocal of circularity value) and AR (major axis/minor axis) obtained from mt-RFP fluorescent images in single cells ( Figs. 2 and 3) (26, 27) . The values of FF and AR represent the mitochondrial shape (fragmentation or elongation) and network (branching; see MATERIALS AND METHODS; Fig. 3B ). MCU, MICU1, and Letm1 overexpression did not change either FF or AR (only AR data was shown), confirming that these two proteins do not change mitochondrial morphology in this cell line (Fig. 4A) . RyR2, which is not expressed in mitochondria, also did not change these two parameters (Fig. 3C) . Recently, coenzyme Q 10 has been identified as an additional Ca 2ϩ uptake pathway (10) . However, coenzyme Q 10 treatment did not show significant changes in mitochondrial morphology in this cell line (Fig. 4B) . Only RyR1 overexpression significantly decreased both FF and AR, indicating that there was significant mitochondrial fragmentation (Fig. 3, B and C) .
The changes in mitochondrial morphology induced by RyR1 overexpression were also observed by EM. In control cells, mitochondrial morphology consisted of a mix of both tubular and round mitochondria, but cells that stably overexpressed mfGFP-RyR1 contained mostly small and round mitochondria (Fig. 3D) . Interestingly, we also found that ER/SR-mitochondrial contact sites were more frequently observed around round mitochondria after overexpression of RyR1 compared with control cells (Fig. 3D, white arrows) . We calculated FF from each mitochondrion observed in EM images and generated a histogram for FF distribution in each group (Fig. 3E) . In control cells, there was one peak distribution near 1 (round mitochondria), but the FF values are widely spread in the range of from 1 to 5 (tubular mitochondria), showing as a two-peak Gaussian fitting (peak values of 1.20 and 1.51). In cells that stably overexpressed mfGFP-RyR1, the distribution pattern of FF lost diversity, and we observed one sharp peak near 1 (round mitochondria), showing as a single-peak Gaussian fitting (peak value of 1.19). In addition, the mean FF value in cells that stably overexpressed mfGFP-RyR1 obtained from EM was significantly decreased compared with control cells, which is consistent with our observations using confocal microscopy (Fig. 3F) .
Next, we addressed the question of whether these changes in mitochondrial morphology are derived from overexpressed RyR1 channel function. Indeed, mitochondrial fragmentation was inhibited by treatment with dantrolene, a RyR1 blocker (8, 85) , whereas treatment with dantrolene itself did not alter any mitochondrial morphology in RyR2-overexpressing or control cells (Fig. 5A ). To definitively confirm that the mitochondrial fragmentation was RyR1 mediated, we tested the effect of RyR1 knockdown on mitochondrial morphology in H9c2 cells that stably overexpressed mfGFP-RyR1. We used the transfection vector encoding siRNA against GFP (63) since mfGFPRyR1 contains the GFP sequence. The knockdown efficiency using this siRNA was first confirmed in H9C2 cells transiently with GFP (Fig. 5B) . The mitochondrial fragmentation in cells that stably overexpressed mfGFP-RyR1 was inhibited by siRNA transfection concomitant with significant knock down of mfGFP-RyR1 (Fig. 5C ), indicating that this effect was mediated through overexpression of RyR1. In contrast, transfection of GFP-siRNA vector in control cells did not show any morphological changes (Fig. 5C ). Because H9c2 cardiac myoblasts do not possess detectable RyR1 before differentiation (see Fig. 1A ) and skeletal myoblasts do (19), we next used the mouse skeletal myoblast cell line (C2C12 cells) as a template of RyR1 knockout and compared those cells with the immortalized RyR1-dyspedic mouse myoblast cell line (1B5 cells; Fig. 5D ) (20) . In C2C12 cells, mitochondrial morphology consisted of a mix of both tubular and round (and small) mitochondria, but 1B5 cells contained only tubular mitochondria. Quantitative analysis of the values of FF and AR also revealed significant differences in mitochondrial shape between C2C12 and IB5 cells ( Fig. 4D; only AR values are shown). The mitochondrial elongation by stable knockdown of RyR1 in 1B5 cells was countered by GFP-RyR1 knockin (Fig.  5D) , suggesting that the RyR1 expression level is critical for mitochondrial morphology.
RyR1 overexpression induces mitochondrial fragmentation through the fission process. The next question is how RyR1 overexpression induces mitochondrial fragmentation. It has been well demonstrated that cardiac cells undergo mitochondrial fission in response to Ca 2ϩ elevation and ROS accumulation (26, 27) , which leads to ⌿ m depolarization (5) and finally to decreased ATP production and increased activation of apoptotic cell death signaling (62) . Since the majority of RyR1 is expressed in the ER/SR after overexpression, we first investigated whether there was an elevation or oscillation of [Ca 2ϩ ] c in H9c2 cells overexpressing RyR1 due to the increased amount of SR Ca 2ϩ leak through overexpressed RyR1 at the SR. Resting [Ca 2ϩ ] c was measured with a doubleindicator ratiometric procedure by loading cells with fluo-3 and fura red (Fig. 6) (30, 31, 38 ). RyR1 overexpression did not change resting [Ca 2ϩ ] c , whereas RyR2 overexpression significantly increased resting [Ca 2ϩ ] c , compared with control cells (Fig. 6, A and B) . In addition, cells that overexpressed RyR1 did not show [Ca 2ϩ ] c oscillation at rest, but cells that overexpressed RyR2 did, which is consistent with results we have previously shown in human embryonic kidney-293 cells (Fig.  6C) (58) . We also found that RyR1 overexpression did not change basal ROS levels in mitochondria measured by the mitochondrial superoxide indicator MitoSox (Fig. 7A) . In addition, there was no significant change in ⌿ m as measured by the ⌿ m -sensitive probe TMRE (Fig. 7B) . These data indicate that the mitochondrial fragmentation by RyR1 overexpression is not likely due to cytosolic Ca 2ϩ elevation, mitochondrial ROS elevation, and/or ⌿ m depolarization.
We (34) have recently reported that glucose stimulation induces mitochondrial fragmentation, ATP production, and insulin secretion without ⌿ m depolarization through the activity of the fission protein DLP1 in an insulinoma cell line (INS-1E cells). This led us to question whether RyR1 overexpression might cause mitochondrial fragmentation through increased fission machinery activation without ⌿ m depolarization in H9c2 cells. First, we performed protein fractionation using cells that stably overexpressed mfGFP-RyR1 and observed the amount of DLP1 in the mitochondria-enriched protein fraction. Interestingly, the mitochondria-enriched protein fraction from mfGFP-RyR1-overexpressing cells contained more DLP1 compared with control cells, indicating that DLP1 activity in mitochondria from mfGFP-RyR1-overexpressing cells is higher than that from control cells (Fig. 8A) . To confirm that the mitochondrial fragmentation by RyR1 overexpression is mediated through DLP1 activity, we transfected a dominant negative mutant of DLP1 (DLP1-K38A) to cells that stably overexpressed mfGFP-RyR1 (83) . Indeed, inhibition of mitochondrial fission by DLP1-K38A eliminated the RyR1 overexpression-induced change in mitochondrial morphology in this stable cell line (Fig. 8B) . These data indicate that RyR1 overexpression induces mitochondrial fragmentation through an acceleration of the fission process (translocation of DLP1 to mitochondria) without cytosolic Ca 2ϩ elevation, mitochondrial ROS elevation, and ⌿ m depolarization.
Fragmented (Fig. 9) . First, we confirmed that this Ca 2ϩ sensor was expressed in mitochondria in H9c2 cells after transfection (Fig. 9A) . Surface membrane depolarization by a high-K ϩ (60 mM) solution (to evoke [Ca 2ϩ ] c elevation) elicited global [Ca 2ϩ ] mt increases that returned to resting levels 60 s after stimulation (Fig. 9, B and C) . We also successfully measured [Ca 2ϩ ] mt changes by 20 nM endothelin (ET)-1 and 3 M thapsigargin (Fig. 9C) . Preincubation with the uncoupler 5 M FCCP (40) significantly inhibited ET-1-induced mitochondrial Ca 2ϩ accumulation (Fig. 9C) . Next, we plotted basal (Fig. 9, E and F) . These observations suggest that mitochondrial form (morphology) and the Ca 2ϩ -handing profile are linked in H9c2 cells.
RyR1 overexpression induces Ca 2ϩ -dependent mitochondrial ATP production. Our data clearly showed that RyR1 overexpression induces mitochondrial fragmentation (Figs. 2,  3 , and 5). Interestingly, fragmented mitochondria in H9c2 cells elicited a sustained [Ca 2ϩ ] mt elevation in response to a cytosolic Ca 2ϩ transient (Fig. 9 ). Since ATP generation is known to be a Ca 2ϩ -dependent process, the next question we examined was how the changes in mitochondrial morphology (fragmentation) by RyR1 and the alteration in [Ca 2ϩ ] mt handing influence mitochondrial metabolism. To test whether RyR1 overexpression can affect ATP production, [ATP] mt was measured using the mitochondrial matrix-targeted FRET-based ATP sensor Ateam by confocal microscopy (see MATERIALS AND METHODS; Fig. 10A) (29, 61, 79) . We confirmed that this ATP sensor was expressed in mitochondria in H9c2 cells after transfection (Fig.  10A ). RyR1-overexpressing cells had higher [ATP] mt under basal conditions, as observed using Ateam (Fig. 10B) . Next, we addressed whether cells that overexpressed RyR1 could produce ATP in response to a cytosolic Ca 2ϩ elevation. Because overexpressed RyR1 was also expressed at the SR, we stimulated cells with ET-1 and mobilized insitol 1,4,5-trisphosphate (IP 3 ) receptor-based SR Ca 2ϩ release (45) to match the magnitude of a cytosolic Ca 2ϩ transient in control and RyR1-transfected cells. We confirmed that ET-1 treatment was able to evoke a [Ca 2ϩ ] mt transient immediately after stimulation (Fig. 9C ). Cells were also treated with 10 g/ml oligomycin A to determine the range of the FRET ratio derived from basal ATP levels in the mitochondrial matrix (Fig. 10C) . ET-1-induced [Ca 2ϩ ] c elevation caused a rapid increase of ATP production in RyR1-overexpressing cells compared with control cells (Fig. 10, C and D) . These results strongly support our hypothesis that Ca 2ϩ influx via mRyR1 is critical in the regulation of mitochondrial morphology (form) and ATP generation (function).
DISCUSSION
In this study, we used RyR1-overexpressing cardiac myoblasts and showed that 1) overexpressed RyR1 is partially expressed in mitochondria but RyR2 is not (Figs. 1 and 2) ; 2) overexpression of RyR1 but not RyR2, MCU, MICU1, or Letm1 or treatment of coenzyme Q 10 leads to mitochondrial fragmentation (Figs. 3 and 4) , which can be blocked by pharmacological inhibition or genetic knockdown of RyR1; 3) RyR1 overexpression induces mitochondrial fragmentation through the fission process but not by [Ca 2ϩ ] c elevation, mitochondrial ROS elevation, and ⌿ m depolarization (Figs.  6 -8 ] c -dependent ATP production (Fig. 10) . These results show that mRyR1 plays an important role in the regulation of both mitochondrial morphology and Ca 2ϩ -dependent ATP production, suggesting distinctive roles of mRyR1 and MCU in the regulation of mitochondrial form and function in cardiac cells (Fig. 11) .
Molecular mechanism underlying mitochondrial localizations of RyR1 in cardiac H9c2 cells. First, we found that overexpressed RyR1 can partially target and localized to mitochondria, but overexpressed RyR2 cannot, which is consistent with our previous observations demonstrating that a small amount of RyR1 (ϳ5% of total RyR), but not RyR2, is expressed in native cardiomyocytes (8) . Here, the important question arises of how RyR1 but not RyR2 is localized in mitochondria.
The precursor forms of mitochondrial nuclear-encoded proteins contain targeting and sorting signals, presented as an NH 2 -terminal signal sequence (e.g., Ref. 32) or within other parts of precursor proteins [e.g., the COOH-term(47)] (for a review, see Ref. 41) , which are essential to direct them to mitochondria. However, the existence of NH 2 -terminal signal sequences is not always indispensable for mitochondrial transport and retention. We can predict the existence of NH 2 -terminal signal sequences and their cleavage sites in these proteins using a computational prediction program named Mitoprot (12) . Indeed, MCU and MICU1, used in this study, possess typical NH 2 -terminal signal sequences (Table 1) . Conversely, other major mitochondrial proteins, such as cyclophilin D and adenine nucleotide translocator, do not possess predictable motifs (Table 1) . RyRs also do not have any predictable NH 2 -terminal signal sequences. Much like cyclophilin D and adenine nucleotide translocator, Mitoprot does not show a high probability of RyR import to mitochondria (Table 1) .
Previous studies have reported that the ER retention signal is likely present within the COOH-terminal portion of RyR1 (9, 53, 78) or RyR2 (22) , which contains transmembrane domains (TMDs). Bhat and Ma (9) reported that amino acids 4918 -4943 of RyR1, which are within TMD6 and have a consensus sequence with the IP 3 receptor and RyR2, contain a strong ER retention signal (Fig. 12 ). Taylor's group (53) showed that TMD1 has a stronger ER localization signal compared with TMD6. Interestingly, they also found that the peptide corresponding to TMD3-TMD4 has the potential to target to mitochondria (53) . Because the sequences of TMD3 in RyR1 and RyR2 have less similarity (60%; Fig. 12A ), the difference in the potential mitochondrial target sequence within the RyR proteins might explain the isoform-specific subcellular localization in cardiomyocytes. Because overexpressed RyR1 in the mitochondrial fraction has a slightly smaller molecular weight than that found in the SR fraction (see Fig. 1C ), it is conceivable that RyR1 in cardiac cells might undergo posttranslational modification (e.g., truncation in the COOH-term portion) and thereby enhance the mitochondrial retention signal located at TMD3-TMD4. Future studies will address the detailed mechanism of RyR1 trafficking to mitochondria, including the clarification of the full sequence of the mRyR1 protein using mass spectrometry.
Molecular mechanism underlying the regulation of mitochondrial form and function by RyR1 in cardiac H9c2 cells: distinct roles of mRyR1 and MCU in the regulation of mitochondrial form and function. The next important finding in this study was that overexpression of RyR1, but not MCU, leads to mitochondrial fragmentation (Figs. 2 and 3 ). This fragmentation is mediated through mitochondrial Ca 2ϩ sequestration via mRyR1 as it is reversed by dantrolene or knockdown of this channel (Fig. 5) . This observation is consistent with our previous finding that an increase in [Ca 2ϩ ] mt induces mitochondrial fragmentation in cardiac cells (27) . We also found that cells that overexpress RyR1 have a higher [ATP] mt under basal conditions and accelerated [Ca 2ϩ ] c -dependent ATP production. This observation is consistent with our previous finding in RyR1 knockout mice that the respiratory control index is very low (Х1) and [Ca 2ϩ ] c does not stimulates O 2 consumption. Our previous reports and present data strongly support our hypothesis that Ca 2ϩ influx via mRyR1 is critical in the regulation of form (mitochondrial morphology) and function (ATP generation).
Interestingly, recent ground-breaking studies have shown that mitochondrial respiration, cell morphology, and cell viability surprisingly remain normal in MCU or MICU1 knockout/-overexpressing cells even though Ca 2ϩ influx is well known to be critical in the regulation of these functions (4, 17, 67) . Our present study using H9c2 cells also confirmed these previous observations demonstrating that overexpression of MCU or MICU1 does not significantly change mitochondrial morphology (Figs. 2 and 4 ). An important question arises as why only RyR1 expression (but not MCU) induces mitochondrial fragmentation and ATP generation (Fig. 7) . There are several possibilities that can explain the unique roles of MCU and mRyR1.
First, the Ca 2ϩ sensitivity and Ca 2ϩ -dependent activation/ inactivation profiles of mRyR1 and MCU are quite different (for reviews, see Refs. 64 and 71 (82) recently demonstrated that an increase in the expression levels of RyRs, by either increasing endogenous expression levels of RyRs via differentiation or overexpression of RyR1 by transfection, can enhance ER/SR-mitochondrial Ca 2ϩ signaling in H9c2 myoblasts. They also speculated that RyRs are an important component for the formation of ER/SR-mitochondrial Ca 2ϩ coupling. In this study, we found that not only the number of fragmented (round) mitochondria increases after overexpression of RyR1 in EM but also that the ER/SRmitochondrial contact sites are frequently observed (see Fig.  3D ). Taken together, it is likely that mRyR1 is one of the determining components for mitochondrial morphology and also the formation of the ER/SR-mitochondrial Ca 2ϩ coupling unit, probably due to overexpressed mRyR1 being preferentially located at mitochondria-SR/ER contact sites. Since MCU is shown to have relatively uniform distribution over the mitochondrion (17, 50) and/or ROS signaling and modulate the activity or subcellular localization of the fission protein DLP1 since we found that DLP1 significantly translocates to mitochondria after RyR1 overexpression (see Fig. 8 ). Further studies will be required to identify the detailed mechanism of how RyR1 overexpression determines DLP1 translocation to mitochondria, especially focusing on the posttranslational modification of DLP1 by Ca 2ϩ and/or ROS signaling (e.g., phosphorylation). The formation of ER/SR and mitochondria contacts could also explain why the fragmented mitochondria have more robust Ca 2ϩ sequestration. ER and mitochondrial networks are intricately intertwined, and it is estimated that 5-20% of the surface of the mitochondrial network are close to the ER surface; therefore, ER/SR-mitochondrial Ca 2ϩ coupling is formed at those contact sites (70). Rizzuto and colleagues (77) showed that division of the mitochondrial network by overex- pression of the mitochondrial fission factor DLP1 (which shows global mitochondrial fragmentation) creates heterogeneity of Ca 2ϩ uptake/release kinetics in each mitochondrion and blocks the propagation of Ca 2ϩ waves in mitochondrial networks in HeLa cells. Indeed, we show here that there is a heterogeneity of mitochondrial Ca 2ϩ handing profiles in tubular/in-network mitochondria and fragmented/out-of-network mitochondria in H9c2 cells (Fig. 8) . It is a reasonable to consider that fragmented mitochondria can sustain [Ca 2ϩ ] mt increases without propagation of Ca 2ϩ to the neighboring mitochondria, which can activate the TCA cycle to increase ATP generation (Fig. 11) . Growing evidence also suggests that the physiological activation of the mitochondrial fission process itself can enhance the efficiency of electron transport chain activity, possibly via the facilitation of forming supercomplexes of the respiratory chain (48, 74) . We (34) have also previously reported that fragmented mitochondria show efficient ATP production without ⌿ m depolarization during glucose stimulation in an insulinoma cell line. Interestingly, the expression pattern of mRyR1 was heterogeneous between each mitochondrion, whereas MCU, MICU1, and Letm1 were homogenously expressed in all mitochondria (Fig. 2, A and B) . In addition, RyR1-overexpressing mitochondria observed in confocal microscopy showed remarkably more round and fragmented morphology ( Fig. 2A, inset) . Collectively, this evidence and our present data strongly support our hypothesis that the expression of mRyR1 modulates mitochondrial morphology (fragmentation) and their Ca 2ϩ -handing profiles, thereby accelerating Ca 2ϩ -dependent ATP production at the matrix (Fig. 11) .
There are several reports that have demonstrated that RyR1 expression is increased in diseased cardiomyocytes. In human heart failure, RyR1 expression increases approximately twofold (57) . In an electrical remodeling model, cultured atrial cells showed an increase of ϳ27-fold RyR1 mRNA (51) . In the present study, we overexpressed RyR1 in H9C2 cells and confirmed that RyR1 increases from undetectable levels to detectable levels in Western blot analysis (see Fig. 1 ) and functionally increase ATP production (see Fig. 10 ). However, we did not carefully quantified how much RyR1 expression is required to increase ATP generation efficiency in this cell line. A future study needs to address whether an increase in RyR1 expression in the diseased heart can alter ATP production.
Taken together, it is likely that Ca 2ϩ influx kinetics via mRyR1 and/or the role of mRyR1 for the formation of ER/ SR-mitochondria coupling units enable maximum ATP production efficiency with a minimum amount of net Ca 2ϩ transport. In contrast, the relatively slower kinetics and lower Ca 2ϩ affinity make MCU an ideal candidate for cytosolic Ca 2ϩ buffering when [Ca 2ϩ ] c increases at ER/SR contact sites under physiological or pathophysiological conditions.
Limitations of this study. As shown in Figs. 1C and 2A, overexpressed RyR1 is partially localized in mitochondria, although the majority of overexpressed RyR1 is localized in the ER/SR. As discussed above, the detailed mechanism of how RyR1 can target to mitochondria is still unclear, and, currently, there is no tool to control the location of overexpressed RyR1. Therefore, we still need to take into account that the changes in mitochondrial morphology and function after RyR1 overexpression might be a secondary effect from the ER/SR-located RyR1, although we could not see any significant effect of RyR1 overexpression on [Ca 2ϩ ] c (Fig. 6 ) and ER/SR-overexpressed RyR2 on mitochondrial morphology (Figs. 2and 3) . Future work is needed to address a physiological role of mRyR1 in the adult cardiomyocyte by knockdown of this channel in situ.
In addition, since it is practically difficult to obtain a 100% pure mitochondria membrane preparation for biochemistry, a future study will further confirm the localization of overexpressed mRyR1 using immunoelectron microscopy, as we have previously reported (7) .
Conclusions. Taken together, our results show the molecular and functional roles of mRyR1 using a RyR1 overexpression system in H9c2 cardiac myoblasts, which clearly distinguish its role from classical MCU. mRyR1 may uniquely work to sequester Ca 2ϩ to generate ATP in myoblasts. Elucidation of the unique biophysical characteristics and physiological functions of the Ca 2ϩ influx mechanism via both MCU and mRyR1 in cardiac myoblasts is significant for our understanding of mitochondrial Ca 2ϩ signaling in the regulation of cardiac physiology and pathophysiology. 
